References
- Rapanotti MC, Caruso R, Bernardini S, et al. Idiopathic hypereosinophilic syndrome:a case evolving in B-lymphoblastic lymphoma. Leuk Res 2005;29:975–979.
- Bain B. The idiopathic hypereosinophilic syndrome and eosinophilic leukemias. Haematologica 2004;89:133–137.
- Ayhan AC, Timur C, Ayhan Y, et al. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report. Acta Haematol 2012;127:90–92.
- Gotlib J. World Health Organization-defined eosinophilic disorders: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012;87:903–914.
- Herling M, Khoury JD, Washington LT, et al. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004;104:328–335.
- Helbig G, Wieczorkiewicz A, Dziaczkowska-Suszek J, et al. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica 2009;94:1236–1241.
- Tefferi A, Gotlib J, Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia:point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 2010;85:158–164.
- Gleich GJ, Leiferman KM. The hypereosinophilic syndromes: current concepts and treatments. Br J Haematol 2009;145:271–285.
- Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica 2009;94:1188–1193.
- Vaklavas C, Tefferi A, Butterfield J, et al. “Idiopathic” eosinophilia with an occult T-cell clone: prevalence and clinical course. Leuk Res 2007;31:691–694.
- Dearden C. How I treat prolymphocytic leukemia. Blood 2012;120:538–551.
- Dungarwalla M, Matutes E, Dearden CE. Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol 2008;80:469–476.
- Kameoka J, Takahashi N, Noji H, et al. T-cell prolymphocytic leukemia in Japan: is it a variant? Int J Hematol 2012;95:660–667.